Impact Factor
4.63
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
8.48
5,871 total citations
h5-index
107
h5 depth signal
Cited share
78.4%
575 of 733
Total citations
5,871
Citation footprint
Metric signal
9.35
External metric anchor
Self-citation
3.3%
191 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
1,773
China
793
Germany
260
United Kingdom
253
Italy
155
Citing Fields of Research
Immunology
1,206
Immunotherapy
675
Viral Identification & Phylogenetics
619
Noncoding RNA
600
Stem Cell Biology
542
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
22,932
Articles tracked across the journal lifetime
Indexed publication set
733
575 cited publications
Last 12 months
583
48.6 publications/month
Open access share
35.7%
208 OA publications in the last year
Leading citing country
United States
1,773 citing publications
Leading citing field
Immunology
1,206 citing publications
Latest tracked publication
17 October 2026
10 recent records available
Coverage & Indexing History
v1n1, Jan. 2000-
v1n1, Jan. 2000-
Active Coverage
Active Coverage
Research Focus & Classification
Indexed Subjects
Immunology
Immunotherapy
Noncoding RNA
Viral Identification & Phylogenetics
Stem Cell Biology
Musculoskeletal Disorders
Issuing & Sponsoring Bodies
Contributor
American Society of Gene Therapy
Broad Categories
Molecular Biology
Therapeutics
Immunology
Viral Identification & Phylogenetics
Hematology
Noncoding RNA
Genetics & Genomics
Musculoskeletal Disorders
MeSH Descriptors
Gene Transfer Techniques
Genetic Therapy
Molecular Biology
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
02
DOI 10.1016/j.ymthe.2026.10.016
Open DOI
The allogeneic eDN70(-) CAR-T Cells Without TCR or MHC Editing Exhibit Enhanced Persistence and Function
03
DOI 10.1016/j.ymthe.2026.10.017
Open DOI
IL-12–producing iPSC-derived antigen-presenting cells enhance antitumor immunity and enable off-the-shelf immunotherapy
04
DOI 10.1016/j.ymthe.2026.10.015
Open DOI
Lentiviral gene therapy corrects the metabolic and immune abnormalities in purine nucleoside phosphorylase-deficient mice
05
DOI 10.1016/j.ymthe.2026.10.014
Open DOI
A natural compound derivative targeting HADHA disrupts mitochondrial homeostasis and suppresses renal cell carcinoma
06
07
08
09
DOI 10.1016/j.ymthe.2026.10.011
Open DOI
News from Biotech
10
DOI 10.1016/j.ymthe.2026.10.009
Open DOI
Five decades of gene therapy innovation and regulation in the US and EU: a historical analysis
Bibliographical & Catalog Notes
Title from cover.
Also issued online.
v. 1, no. 1 (Jan. 2000)20000717 Notice published Printed on acid-free paper that meets the full ANSI standard for Permanent Paper Printed on acid-free paper